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Objective The present study aimed to investigate the psychrophilic properties of Yersinia enterocolitica and
Yersinia pseudotuberculosis as contaminants of donated blood.
Methods Bags with red blood cell concentrates (RBCCs) of A, B, and AB blood groups were inoculated with a
bacterial suspension of Y. enterocolitica (0 : 3 and 0 : 8) and Y. pseudotuberculosis (serovars I and III) and stored
at 4 8C for 30 days. Bacterial growth was measured at selected intervals after inoculation. Initial strains
and their subcultures (isolated after 30 days’ incubation at 4 8C) were tested for glycolytic activity and
susceptibility to the bactericidal action of human serum.
Results It was found that all strains grew well in the RBCCs of A, B, and AB groups. After incubation at 4 8C
they increased their glycolytic activity and became more sensitive to the killing ability of human serum.
Conclusions The prolonged storage of contaminated Y. enterocolitica and Y. pseudotuberculosis RBCCs at 4 8C
induces bacterial multiplication to high levels and stimulates glycolytic activity of bacterial cells.
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INTRODUCTION
Blood transfusion sometimes initiates transmission of patho-
genic bacteria, which increases the risk of bacteremia and
septicemia. Transfusion of Yersinia enterocolitica-infected blood
is rare, but fatal complications during blood transfusion have
been reported [1].
The organisms probably originate from bacteremia in the
donor and can subsequently multiply at low temperatures [2].
Y. enterocolitica grows well at 4 8C and in the presence of dextrose
and iron. If blood is contaminated at the time of collection,
storage of the red blood cells at 4 8C provides an ideal environ-
ment for bacterial growth and endotoxin production [3]. The
aim of this study was to investigate the effect of long cold storage
(4 8C) on bacterial growth and some properties of Y. entercolitica
and Y. pseudotuberculosis in donated red blood cell concentrates
(RBCCs) of different ABO groups.
MATERIALS AND METHODS
Bacterial strains
The strains used in this study were Y. enterocolitica 201/86,
serovar 0 : 3, biovar 4 (plasmid-bearing); Y. enterocolitica 653,
serovar 0 : 8, biovar 1B (plasmid-bearing); Y. pseudotuberculosis
32981, serovar I (plasmid-bearing); and Y. pseudotuberculosis
Mollaret, serovar III (plasmidless). The strains of Y. enterocolitica
were a kind gift of Prof. G. Kapperud (Norway) and were
obtained from patients. The strains of Y. pseudotuberculosis were
isolated from animals and kindly provided by Prof. H. Mollaret
(France). A suspension of the test microorganisms was prepared
from an overnight culture on tryptic soy agar (Difco, USA),
diluted to 103 cells/mL in saline and then used to inoculate the
RBCCs.
Blood processing and inoculation
The freshly donated blood from groups A, B, and AB was
primarily processed in the regional Blood Bank Center in Sofia.
Red blood cells were separated in bags by standard methods.
The bags were inoculated with bacterial suspension of strains
Y. enterocolitica 201/86, Y. enterocolitica 653, Y. pseudotuberculosis
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32981, and Y. pseudotuberculosis Mollaret, so that the final
bacterial concentration in each bag was 102 cells/mL for each
strain. All bags were incubated at 4 8C and stored for 30 days.
There was one non-inoculated control bag from each ABO
blood group (A, B, and AB). During storage, samples were
collected periodically (at 1, 3, 7, 15 and 30 days) and colony
counts of serial dilutions were performed by plating on tryptic
soy agar (Difco). Initial strains and their subcultures (isolated
after 30 days of incubation at 4 8C) were tested for glycolytic
activity and susceptibility to the bactericidal action of human
serum.
Glycolytic activity of bacterial cells
Glycolysis was assayed essentially as described earlier by Radou-
cheva et al. [4]. One milliliter of bacterial suspension with a
density of 2 107 cells/mL was added to a reaction mixture
containing the following components in 2.5 mL: 80 mmol of
Tris buffer (pH 7.2), 60 mmol of glucose and 25 mmol of KCN.
After a 2 h incubation at 37 8C without shaking, 0.5 mL (for
each sample) of 30% trichloracetic acid was added. The amount
of lactic acid was determined in protein-free supernatant. In the
presence of sulfuric acid and b-hydroxy-biphenil, the lactic acid
was converted to a chromophore and absorption measured at
l 540 nm in a Zeiss Spekol model 11 spectrophotometer
(Zeiss, Jena, Germany). The results were expressed as mg of
lactic acid released by 2 107 cells in 2 h.
Serum bactericidal assay
The serum bactericidal assay was carried out according to the
method of Pai and DeStephano [5]. Serial twofold dilutions of
human test serum were performed. Overnight cultures of
Y. enterocolitica 201/86, Y. enterocolitica 653, Y. pseudotuberculosis
32981, and Y. pseudotuberculosis Mollaret were rinsed twice
and suspended in saline to 5 103 colony-forming units
(CFU)/mL. Bacteria were added to each serum dilution (in
100 mL volumes, 1 : 1 v/v). At time zero and after 2 h incubation
at 37 8C, samples (0.1 mL) from each serum dilution were plated
on meat peptone agar. CFU were counted after 48 h of
incubation at 25 8C. The serum dilution ensuring 50%
reduction of the initial bacterial inoculum during 120 min
incubation of bacteria–serum mixture at 37 8C was accepted
as the bactericidal titer.
Statistical analysis
The results were expressed as mean values standard devia-
tion in order to assess the significance of differences within
experiments. Student’s t-test was used. Statistical significance
was defined as P< 0.01. Experiments were repeated three
times.
RESULTS
All Y. enterocolitica and Y. pseudotuberculosis strains demonstrated
the ability to grow well for a period of 30 days in human
RBCCs of A, B, and AB groups at 4 8C. After a lag period
of at least 3 days, all strains entered a phase of exponential
growth, which continued until the end of experiment (day 30).
It was found that the final bacterial counts of Y. enterocolitica 0 : 3,
i.e. (4.5 0.5) 1011 in group A, (3.4 0.4) 1010 in group
B, and (6.6 0.7) 1011 in group AB; and of Y. enterocolitica
0 : 8, i.e. (1.3 0.2) 1011 in group A, (2.1 0.3) 1010 in
group B, and (4.2 0.5) 1011 in group AB, were higher than
those of Y. pseudotuberculosis serovar I, i.e. (2.2 0.3) 1010 in
group A, (2.1 0.2) 109 in group B, and (4.9 0.6) 1010 in
group AB; and of Y. pseudotuberculosis serovar III, i.e.
(4.2 0.6) 109 in group A, (1.3 0.4) 108 in group B,
and (1.3 0.2) 1010 in group AB. Statistically significant
correlations between blood group type (A, B, or AB) and
growth capacity of strains were not found.
The results of glycolytic activity tests are summarized in
Figure 1. After incubation at 4 8C in RBCCs, all strains
increased their glycolytic activity. The strains of Y. enterocolitica
were more active than those of Y. pseudotuberculosis. There were
statistically significant differences in the values (at P< 0.01)
between Y. enterocolitica and Y. pseudotuberculosis. The strains
isolated after incubation in the RBCCs of blood group B
showed high levels of glycolytic activity (Y. enterocolitica
Figure 1 Glycolytic activity ofYersinia enterocolitica andYersinia pseudotu-
berculosis after 30 days of incubation at 4 8C in blood bags with red cells
concentrate. Y. enterocolitica 201/86 serovar 0 : 3; Y. enterocolitica
653 serovar 0 :8; Y. pseudotuberculosis 32981serovar I; Y. pseudotu-
berculosisMollaret servor III.
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201/86 serovar 0 : 3, 176 11 mg of lactic acid; Y. enterocolitica
653 serovar 0 : 8, 179 16 mg; Y. pseudotuberculosis 32981 serovar
I, 134 19 mg of lactic acid; Y. pseudotuberculosis Mollaret
serovar III, 110 12 mg). The strains incubated in blood group
A were the least active.
The strains isolated after incubation in blood cell concen-
trates at 4 8C were tested for susceptibility to the bactericidal
action of human serum. As presented in Table 1, all strains
showed a trend to increase their susceptibility to the killing
ability of the test serum. The strains of Y. pseudotuberculosis were
more sensitive. The bactericidal titer for Y. enterocolitica 201/86
serovar 0 : 3 increased from 1 : 8 (initial strain) to 1 : 64 (three
times) in RBCCs of group A, to 1 : 32 (two times) in RBCCs of
group B, and to 1 : 64 (three times) in RBCCs of group AB.
The bactericidal titer for Y. enterocolitica 653 serovar 0 : 8
increased from 1 : 4 (initial strain) to 1 : 16 (two times) in
RBCCs of group A, to 1 : 8 (one time) in RBCCs of group
B, and to 1 : 16 (two times) in RBCCs of group AB. The
bactericidal titer for Y. pseudotuberculosis 32981 serovar I
increased from 1 : 4 (initial strain) to 1 : 64 (four times) in
RBCCs of group A, to 1 : 32 (three times) in RBCCs of group
B, and to 1 : 64 (four times) in RBCCs of group AB. The results
for Y. pseudotuberculosis Mollaret serovar III were similar.
DISCUSSION
Contamination of donated blood has been reported in several
cases of blood transfusion. Among the bacterial strains, Y.
enterocolitica has emerged as a significant cause of transfusion-
associated bacteremia and mortality [1,6]. Tipple et al. [3]
investigated seven cases of transfusion-associated Y. enterocolitica
sepsis: four were caused by organisms of serotype 0 : 3, and one
each was caused by organisms of serovar 0 : 1, 2, 3, 0 : 5, 27, and
0 : 20. Review of the cases presented by Bottone [6] reveals that
serogroup 0 : 3 Y. enterocolitica accounts for 15 (55%) of the 27
episodes of transfusion-acquired Y. enterocolitica, followed by
serogroups 0 : 9, 0 : 5, 27, 0 : 123, and 0 : 20. Unlike most other
contaminants of blood components, Y. enterocolitica can actively
multiply at refrigerator temperatures (4 8C) during blood
storage and can cause severe reactions in recipients. Our
previous study demonstrated that, in contrast to Salmonella
typhimurium and Stophylococcus aureus, which showed a trend
to die out during a 30-day incubation period at 4 8C in RBCCs,
Y. entercolitica and Y. pseudotuberculosis multiplied rapidly to large
numbers [7]. It is supposed that Y. entercolitica may persist in
human tissues and can enter donated blood as a result of
transient bacteremia [8].
In the present study it was observed that all strains were
capable of growth at 4 8C in the RBCCs of A, B, and AB
groups. Results of the glycolytic activity studies indicated that
glycolysis increased in all tested strains. Incubation at a low
temperature in human RBCCs in our experiment had a positive
effect on the catabolic metabolism of all strains. It is known that
the level of glycolytic activity is accepted as an indicator for the
energy metabolism of organisms. Obviously, the enhanced
catabolism of glucose taking place during ‘cold’ cultivation
of Y. enterocolitica and Y. pseudotuberculosis ensures the increased
physiological needs of bacterial cells and appears to be a part of
the adaptive metabolic manifestation in these bacteria. Somov
and Varvashevich [9] suggest that low temperature, in combi-
nation with other definite factors, triggers the activity of certain
isoenzymes in Y. pseudotuberculosis that function only at low
temperatures. In fact, there are no data on Y. pseudotuberculosis as
a contaminant of blood products. The effect of low positive
temperature on the growth capacity of Y. enterocolitica and Y.
pseudotuberculosis has been widely studied [10–13]. Long periods
of incubation at low positive temperatures led to a higher degree
of adaptation [14]. Increased phenotypic tolerance to cold is
accompanied by the synthesis of proteins involved in different
functions [4]. It is known that Y. enterocolitica and Y. pseudotu-
berculosis can accumulate Fe3þ and can use hemin as a sole source
of iron. They possess an efficient cell-bound transport system
for Fe3þ [15]. Tipple et al. [3] suggest that Y. enterocolitica growth
in human blood may be enhanced by iron liberated from aging
erythrocytes and also by saline–dextrose solution, which is used
for the collection and resuspension of erythrocytes.
Experiments involving serum sensitivity tests showed that all
strains increased their susceptibility to the bactericidal action of
serum after incubation in RBCCs at 4 8C for 30 days in
different grades. Resistance to serum bactericidal activity of
Table 1 Susceptibility ofY. enterocolitica andY. pseudotuberculosis, isolated after 30days of incubation in red blood cells concentrate at 4 8C to bactericidic
activity of human serum
Titre after incubation in blood of Group:
Strain
Initial titre
(prior to incubation) A
a Ba ABa
Y. enterocolitica 201/86 serovar 0 : 3 83.59b 6428.79c 3214.39 6424.19c
Y. enterocolitica 653 serovar 0 :8 41.51 167.20 83.60 167.20
Y. pseudotuberculosis 32981serovar I 41.51 6412.09c 3214.40 6428.79c
Y. peudotuberculosisMollaret serovar III 83.60 12824.19c 6412.09c 12824.19c
aBlood group; bmean standard deviation serum titers; csignificant differences from control strains (P<0.01).
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yersinial cells is manifested at 37 8C and correlated with pre-
sence of two outer membrane proteins – YadA (plasmid
encoded) and Ail or Inv (chromosomally encoded). Yersinial
cells growing at lower temperatures have low copy numbers of
these proteins [6,16,17]. So, at 4 8C, the plasmid is no longer
expressed, synthesis of these proteins is down-regulated, and the
bacterial cells become sensitive to serum [18].
We did not find any significant influence of ABO blood type
on the growth capacity of Yersinia strains. Interestingly, we noted
that, after incubation, isolated strains in blood group B demon-
strated the most activated glycolytic activity. It could be sug-
gested that the regulation of adaptive metabolism in Y.
enterocolitica and Y. pseudotuberculosis is a complex process
depending at least on specific species and strain properties,
and on environmental (host) factors.
CONCLUSION
In conclusion, Y. enterocolitica and Y. pseudotuberculosis demon-
strate adequate metabolic reorganization, successful adaptation
and multiplication to high levels during long storage in donated
RBCCs at 4 8C, which makes them particularly dangerous as
contaminants.
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